FDA recalls two lots of drug to treat hyperkalemia
A sample of one affected lot tested positive for a strain of yeast.
The U.S. Food & Drug Administration has recalled two lots of Roxane Laboratories, Inc.'s Sodium Polystyrene Sulfonate Suspension, USP, 15 g/60 mL Unit dose bottles (NDC 0054-0165-51; lot 856396A Exp April 2010, and lot 856693A Exp May 2010), a product used to treat hyperkalemia. A sample of one affected lot tested positive for a strain of yeast, which may affect immunocompromised patients.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
